Votumumab
Votumumab
Votumumab (pronunciation: vo-tu-mu-mab) is a type of monoclonal antibody used in the treatment of certain types of cancer. It is a biological therapy that works by targeting specific proteins on the surface of cancer cells.
Etymology
The name "Votumumab" is derived from the Latin word "votum", meaning "vow" or "promise", and "mab", an abbreviation for "monoclonal antibody". This reflects the drug's promise in the field of oncology.
Usage
Votumumab is used in the treatment of various types of cancer, including melanoma, non-small cell lung cancer, and colorectal cancer. It works by binding to specific proteins on the surface of cancer cells, thereby inhibiting their growth and proliferation.
Related Terms
- Monoclonal antibody: A type of protein made in the lab that can bind to substances in the body, including cancer cells.
- Biological therapy: Treatment to stimulate or restore the ability of the immune system to fight cancer, infections, and other diseases.
- Oncology: The study of cancer and its treatment.
- Melanoma: A form of skin cancer that begins in the cells (melanocytes) that control the pigment in your skin.
- Non-small cell lung cancer: The most common type of lung cancer.
- Colorectal cancer: A cancer that starts in the colon or the rectum.
External links
- Medical encyclopedia article on Votumumab
- Wikipedia's article - Votumumab
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski